Free Trial

Oppenheimer (NYSE:OPY) Shares Pass Above 200 Day Moving Average - What's Next?

Oppenheimer logo with Finance background

Oppenheimer Holdings Inc. (NYSE:OPY - Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $62.69 and traded as high as $63.60. Oppenheimer shares last traded at $63.40, with a volume of 31,807 shares trading hands.

Oppenheimer Trading Down 0.2%

The firm has a market capitalization of $655.92 million, a P/E ratio of 9.78 and a beta of 1.22. The company has a quick ratio of 0.80, a current ratio of 1.29 and a debt-to-equity ratio of 0.13. The firm has a 50 day moving average of $60.62 and a 200-day moving average of $62.72.

Oppenheimer (NYSE:OPY - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The financial services provider reported $2.72 earnings per share (EPS) for the quarter. The firm had revenue of $367.83 million for the quarter. Oppenheimer had a net margin of 5.00% and a return on equity of 8.76%.

Oppenheimer Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, May 23rd. Shareholders of record on Friday, May 9th were issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date was Friday, May 9th. Oppenheimer's dividend payout ratio is presently 10.71%.

Insider Buying and Selling

In other news, Director Paul M. Friedman sold 3,500 shares of the company's stock in a transaction on Monday, June 9th. The shares were sold at an average price of $63.32, for a total transaction of $221,620.00. Following the completion of the transaction, the director now directly owns 20,500 shares in the company, valued at approximately $1,298,060. This represents a 14.58% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 34.25% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Oppenheimer

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Boston Partners raised its holdings in Oppenheimer by 457.7% during the 1st quarter. Boston Partners now owns 71,568 shares of the financial services provider's stock worth $4,268,000 after purchasing an additional 58,735 shares during the last quarter. Royce & Associates LP raised its position in shares of Oppenheimer by 114.8% in the 1st quarter. Royce & Associates LP now owns 80,551 shares of the financial services provider's stock worth $4,803,000 after acquiring an additional 43,050 shares in the last quarter. Invesco Ltd. lifted its stake in shares of Oppenheimer by 864.7% in the 1st quarter. Invesco Ltd. now owns 41,596 shares of the financial services provider's stock valued at $2,480,000 after purchasing an additional 37,284 shares during the period. American Century Companies Inc. boosted its position in shares of Oppenheimer by 17.2% during the 1st quarter. American Century Companies Inc. now owns 227,389 shares of the financial services provider's stock valued at $13,559,000 after purchasing an additional 33,433 shares in the last quarter. Finally, Boothbay Fund Management LLC acquired a new stake in Oppenheimer during the fourth quarter worth approximately $1,717,000. Institutional investors own 32.26% of the company's stock.

Oppenheimer Company Profile

(Get Free Report)

Oppenheimer Holdings Inc operates as a middle-market investment bank and full-service broker-dealer in the Americas, Europe, the Middle East, and Asia. The company provides brokerage services covering corporate equity and debt securities, money market instruments, exchange-traded options and futures contracts, municipal bonds, mutual funds, exchange-traded funds, and unit investment trusts; financial and wealth planning services; and margin lending services.

See Also

Should You Invest $1,000 in Oppenheimer Right Now?

Before you consider Oppenheimer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oppenheimer wasn't on the list.

While Oppenheimer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines